Key result
H-FABP assays detect only ~58% of acute MIs, demonstrating lower sensitivity than initial troponin.
Why the study?
Previous studies have shown inconsistent correlation of heart-type fatty acid-binding protein with standard cardiac biomarkers for early diagnosis of myocardial infarction.
Does H-FABP measurement improve the early diagnosis of acute myocardial infarction compared to standard troponin assays in patients admitted with acute coronary syndrome?
Observational (n=50)
Does H-FABP measurement improve the early diagnosis of acute myocardial infarction compared to standard troponin assays in patients admitted with acute coronary syndrome?
Answers are grounded in this paper and cite their sources.
H-FABP assays do not provide earlier detection or increased sensitivity compared to standard troponin assays for diagnosing acute myocardial infarction, limiting their diagnostic utility.
BACKGROUND: Heart-type fatty acid-binding protein (H-FABP) is a membrane-bound protein that facilitates transport of fatty acids from the blood into the heart. It is currently being used outside the United States for the early diagnosis of myocardial infarction (MI). However, previous studies have shown inconsistent correlation of H-FABP with standard cardiac biomarkers. METHODS: Fifty patients admitted with ST segment elevation MI (n=25), non-ST segment elevation MI (n=15) or unstable angina (n=10) were evaluated. The CardioDetect med cardiac infarction test (rennesens GmbH, Germany) was used to measure both qualitative and quantitative H-FABP. RESULTS: Of the 40 patients with acute MI, the initial troponin assay was positive in 35 patients (88%), the qualitative H-FABP assay was positive in 23 patients (58%) and the quantitative H-FABP assay was positive in 15 patients (38%) (P=0.001). No patient with MI had a positive H-FABP assay with a negative initial troponin assay. CONCLUSION: In the present study, the results of both the qualitative and quantitative H-FABP assays neither appeared earlier nor provided increased sensitivity compared with troponin in diagnosing acute MI. Accordingly, the use of H-FABP as a diagnostic tool for MI is limited.
No takes yet. Share an insight, caveat, or question.
Rosman et al. (2009) conducted an observational in Acute coronary syndrome (n=50). Heart-type fatty acid-binding protein (H-FABP) assay vs. Troponin assay was evaluated on Positive assay in patients with acute MI (p=0.001). Qualitative and quantitative H-FABP assays were positive in 58% and 38% of acute MI patients, respectively, compared to 88% for the initial troponin assay.
Synapse has enriched 10 related papers. Consider them for comparative context: